Raul D Santos

Raul D Santos is an expert in Cardiology at Hospital Israelita Albert Einstein (Brazil). As of October 2026, ScienceLeadR ranks Raul D Santos in the top 1% of experts worldwide for Hypercholesterolemia, Hyperlipidemias and Dyslipidemias. Raul D Santos has authored 747 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 2,693 (community average: 125). How the SLR is computed.

Cardiology

Subspecialties: Endocrinology - Biochemistry - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 19, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2000 - 2026

Source: PubMed

Hospital Israelita Albert Einstein

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 747

Citations

Citations: 44 188 1st author: 76 Last author: 159 Unique author: 48

Main journals

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
GLP-1 receptor agonists and SGLT2 inhibitors in cardiovascular practice: insights from a national survey of French cardiologists. PMID 42877716 — glucagon-like peptide 1, sodium-glucose transporter 2 inhibitors, glucagon-like peptide-1 receptor, cardiologists	Arch Med Sci	2026	0
Partitioning ApoB in the context of Lipoprotein(a) concentrations: A Necessary but Incomplete Step Toward Defining Plaque Phenotype. PMID 42867363 — lipoproteins, cardiovascular diseases, phenotype, lipoprotein(a), apolipoproteins b	Eur J Prev Cardiol	2026	0
Lp(a) testing and treatment with Lp(a)-lowering therapies in the primary and secondary prevention of cardiovascular disease in high income countries: A preliminary health technology assessment. PMID 42526419 — research design, cardiovascular diseases, income, secondary prevention, risk factors, therapeutics, technology assessment, biomedical, lipoprotein(a)	Atherosclerosis	2026	0
Digitally Enabled Quality Improvement Intervention and LDL-C Control in Atherosclerotic Cardiovascular Disease: The SAPPHIRE-LDL Cluster Randomized Clinical Trial. PMID 42485013 — cholesterol, ldl, cardiovascular diseases, odds ratio, therapeutics, quality improvement	JAMA Cardiol	2026	1
HDL Functionality, CETP Inhibitors, and Exercise Training: Where are We? PMID 42484214 — exercise, cardiology	Arq Bras Cardiol	2026	0

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Director: 1

By phase:

Phase 3 10

N/A 5

Phase 4 2

Phase 2/Phase 3 1

By status:

Completed 13

Recruiting 2

Terminated 2

Not yet recruiting 1

By type:

Interventional 15

Observational 3

By Monocentric/Multicentric:

monocentric 4

multicentric2to4 1

multicentric5to9 0

multicentricup10 13

Main Topics

Nutritional and Metabolic Diseases 11

Congenital, Hereditary, and Neonatal Diseases and Abnormalities 8

Cardiovascular Diseases 7

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Personalise Antidepressant Treatment for Unipolar Depression Combining Individual Choices Risks and Big Data NCT05608330 — big data, depression, antidepressive agents, decision making, shared, clinical reasoning, decision making, depressive disorder, drug-related side effects and adverse reactions, therapeutics, demography, depressive disorder, major	N/A	Not yet recruiting	2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice